Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
        • Real stories
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Careers and studies
        • Contact
  • Donate
    Centenary Institute > People > Professor Philip Hansbro

Professor Philip Hansbro

Deputy Director, Centenary Institute;
Director, Centenary UTS Centre for Inflammation

Programs

  • Centenary UTS Centre for Inflammation

Phone number Phone Number +61 2 9565 6248

Email Email p.hansbro@centenary.org.au

Profile Linkedin Profile

Professor Phil Hansbro is an internationally recognised research leader in the study of respiratory diseases, such as asthma, chronic obstructive airway disease (COPD, aka emphysema) and infections and is developing interests in lung cancer. His work is substantially contributing to understanding the pathogenesis and developing new therapies for these diseases.

His work has made internationally important contributions and led to the identification of novel avenues for therapy that are under further study. This is achieved through the development of novel mouse models that recapitulate the hallmark features of human disease, including infections, asthma and COPD and now lung cancer. He employs these models in integrated approaches (infection, immunity and physiology with particular expertise in lung function analysis) to understand human diseases, and develop new treatment strategies. Research outcomes have a translational goal and his studies are conducted in parallel with collaborative human studies with clinical researchers.

Research

  • Centenary UTS Centre for Inflammation

    Inflammation is increasingly being found to play crucial roles in the development of many major diseases, i­ncluding Alzheimer’s, heart disease, cancer, respiratory diseases, diabetes, tuberculosis and COVID-19.
    Read more

Themes

  • Cancer

    Cancer
  • Inflammation

    Inflammation

Research Fields

  • Asthma
  • COPD – Chronic obstructive pulmonary disease
  • Lung Cancer

Topics

  • Chronic diseases ,

Publications

Recent publications

Search amongst our repository

all publications

For access to all Publications via Pub Med.

Research

  • Centenary UTS Centre for Inflammation

    Inflammation is increasingly being found to play crucial roles in the development of many major diseases, i­ncluding Alzheimer’s, heart disease, cancer, respiratory diseases, diabetes, tuberculosis and COVID-19.
    Read more

News

  • Study shows early changes in immune cells linked to COPD

    A new study led by the Centenary Institute and the University of Bonn has revealed new insights into the early stages of chronic obstructive pulmonary disease (COPD), a debilitating respiratory condition characterised by inflammation in the lungs and severe breathing difficulties.
    Date 30 May 2023
  • Event celebrates ‘The Good Gut Anti-Inflammatory Diet’

    The Centenary Institute has celebrated the publication of a new book, 'The Good Gut Anti-Inflammatory Diet’ at a special event, held at the Dymocks Bookstore, Sydney.
    Date 13 Feb 2023
  • Good Gut Anti-Inflammatory Diet book released

    A new book, ‘The Good Gut Anti-Inflammatory Diet’, has been released by the Centenary Institute, which is full of informative knowledge, recipes and advice to maintain good gut health to control inflammation and to help prevent disease.
    Date 10 Jan 2023
    The Good Gut Anti-inflammatory Diet book The Good Gut Anti-inflammatory Diet book
  • Discovery could open door to new COPD treatment

    Research led by the Centenary Institute, the University of Technology Sydney and Ghent University Hospital, Belgium has identified a new therapeutic approach for chronic obstructive pulmonary disease (COPD) – the targeting and inhibition of a protein called RIPK1.
    Date 03 Jan 2023
  • Annual NSW Asthma Meeting held at Centenary

    The Centenary UTS Centre for Inflammation has hosted the 16th Annual NSW Asthma Meeting (NAMe) held at the Centenary Institute, 17-18 November 2022.
    Date 21 Nov 2022
  • $5M grant to investigate relationship between gut and lung in respiratory disease

    Australian researchers have been awarded a $5 million National Health and Medical Research Council (NHMRC) Synergy Grant for a project that will advance knowledge of the gut, microbiomes, metabolites and diet, and their role in both causing and potentially treating inflammatory respiratory diseases, particularly chronic obstructive pulmonary disease (COPD).
    Date 21 Oct 2021
  • Cell death discovery could lead to new treatment for COPD

    Research shows that inhibiting necroptosis, a form of cell death, could be a novel therapeutic approach for treating chronic obstructive pulmonary disease (COPD), an inflammatory lung condition, also known as emphysema, that makes it difficult to breathe.
    Date 16 Jun 2021
View all

Twitter

Tweets by CentenaryInst Follow us (links open in a new window)

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram